Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Scleroderma--systemic sclerosis. Serology, lung function and survival].

S Ullman1, P Halberg, A Wiik

  • 1Dermatologisk afdeling, H:S Bispebjerg Hospital.

Ugeskrift for Laeger
|June 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals.

Journal of endocrinological investigation·2024
Same author

Posterolateral corner injuries: Epidemiology, anatomy, biomechanics and diagnosis.

Injury·2017
Same author

Internal fixation of femoral neck stress fractures in young female athletes with a dynamic locking plate.

Acta orthopaedica Belgica·2015
Same author

Gait asymmetry detection in older adults using a light ear-worn sensor.

Physiological measurement·2014
Same author

Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.

Scandinavian journal of rheumatology·2013
Same author

Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.

Clinical and experimental rheumatology·2013
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Systemic sclerosis patients frequently have antinuclear antibodies (ANA), with specific types linked to disease subtypes and pulmonary function. Diffuse SSc and younger age correlate with higher mortality rates.

Area of Science:

  • Rheumatology
  • Immunology
  • Pulmonology

Context:

  • Systemic sclerosis (SSc) is a complex autoimmune disease with varied clinical presentations.
  • Understanding the serological markers and their associations is crucial for patient management.
  • Pulmonary involvement and mortality are significant concerns in SSc patients.

Purpose:

  • To investigate the prevalence of antinuclear antibodies (ANA) in SSc patients.
  • To correlate specific autoantibodies (anti-centromere, anti-Scl-70, anti-U1-RNP) with clinical phenotypes, pulmonary function, and mortality.
  • To analyze factors influencing pulmonary function decline and overall survival in SSc.

Summary:

  • 85% of studied SSc patients tested positive for ANA.
  • Anti-centromere antibodies (34%) were associated with limited SSc, anti-Scl-70 (13%) with diffuse SSc, and anti-U1-RNP (6.5%) with myositis/arthritis.

Related Experiment Videos

  • Reduced diffusion capacity was common (47%), worsening with anti-centromere antibodies and elevated sedimentation rate.
  • The standardized mortality rate (SMR) was 2.9, significantly higher in young patients (SMR=13) and those with diffuse SSc (SMR=4.5).

    • Impact:

    • Identifies key autoantibodies as biomarkers for SSc subtypes and disease progression.
    • Highlights the significant impact of pulmonary diffusion capacity reduction on SSc patients.
    • Provides critical data on mortality risk factors in SSc, particularly for diffuse SSc and younger individuals.